Manager TitleAgeSince
President - 09/10/2025
Corporate Officer/Principal - 24/04/2018
Date Insider Type Main position Quantity % Market Cap. Importance
09/10/25 Issuer sale

Director

30,002 0.0676%
09/10/25 Issuer sale

Chief Executive Officer

65,675 0.1480%
09/10/25 Issuer sale

Director

784,404 1.7671%
Change 5-day change 1-year change 3-year change Capi.($)
-1.85%-7.45% - - 9.52M
-0.16%+1.59%+34.41%+103.29% 132B
-0.64%+1.60%+34.00%+76.94% 23.24B
-1.59%+1.89%+25.58%+56.81% 17.5B
-0.16%+0.58%+18.21%+27.23% 14.98B
-0.95%-1.75%-0.90%+5.44% 14.78B
+2.27%-8.17%-0.41%+108.95% 14.29B
+2.01%+2.19%-9.84%+57.70% 13.1B
+0.78%+4.84%+64.77%+85.98% 12.74B
-0.44%+1.57%+31.49%+41.14% 12.42B
Average -0.08%+0.82%+21.92%+62.61% 28B
Weighted average by Cap. -0.07%+1.32%+27.92%+81.62%
Logo ESSA Pharma Inc.
ESSA Pharma Inc. is a Canada-based pharmaceutical company that was previously focused on developing therapies for the treatment of patients with prostate cancer. The Company is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.
Employees
35
  1. Stock Market
  2. Stocks
  3. EPIX Stock